Exclusive translation: A study conducted on a new vaccine for pancreatic cancer revealed amazing results regarding the potential of the vaccine to treat tumors as well as prevent the disease from returning.
And according to the British newspaper, “Daily Mail”, a quarter of patients only live a year or more following being diagnosed with this type of pancreatic cancer, which is not easily detected, because the immune system does not consider its presence a “threat”.
The results of the early experiments with this vaccine indicate that according to a test that included 16 people with pancreatic cancer, they were applied to this vaccine, in which the technology was used mRNA Similar to the Corona vaccine, it stimulates the body to prevent the return of this tumor once more.
And the scientists discovered, according to the newspaper, that the vaccine succeeded in activating the cells of 8 patients who were tested, and that they remained safe 18 months following the surgery.
